ASEP Medical Holdings Inc. (CSE:ASEP)

Canada flag Canada · Delayed Price · Currency is CAD
0.230
-0.030 (-11.54%)
At close: Feb 27, 2026
-64.62%
Market Cap 2.56M
Revenue (ttm) 296.77K
Net Income (ttm) -7.84M
Shares Out 11.12M
EPS (ttm) -0.83
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 973
Average Volume 13,801
Open 0.230
Previous Close 0.260
Day's Range 0.230 - 0.230
52-Week Range 0.090 - 1.000
Beta -1.49
RSI 41.79
Earnings Date May 1, 2026

About ASEP Medical Holdings

ASEP Medical Holdings Inc., together with its subsidiaries, engages in the acquisition of research and development assets, technologies, and businesses in the area of life sciences and medical diagnostics. It offers peptide technologies that cover therapeutic applications, including bacterial biofilm infections, anti-inflammatory, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and antifouling coating. The company was fo... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol ASEP
Full Company Profile

Financial Performance

In 2024, ASEP Medical Holdings's revenue was 297,586, an increase of 1307.69% compared to the previous year's 21,140. Losses were -8.27 million, 0.55% more than in 2023.

Financial Statements

News

There is no news available yet.